EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Stromagenesis and cancer‐associated fibroblast heterogeneity in primary tumors and metastasis: focus in non‐small cell lung cancer

Alejandro Bernardo iD, Natalia Díaz-Valdivia iD, Patricia Fernández-Nogueira iD, Jordi Alcaraz iD

FEBS Open Bio · 2025-10 · 15 (10) · 1599-1617

DOI: 10.1002/2211-5463.70102 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift FEBS Open Bio, online erschienen am 04.09.2025. Verfasst von Alejandro Bernardo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Biophysics and Bioengineering, Department of Biomedicine, University of Barcelona, Spain. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Cancer-Associated Fibroblasts. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades (Agencia Estatal de Investigación AEI/FEDER, UE), Instituto de Salud Carlos III, Fondo Nacional de Desarrollo Científico y Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non‐small cell lung cancer (NSCLC) is the most common lung cancer type and one of the deadliest neoplasias worldwide. NSCLC is histologically classified into adenocarcinoma, squamous cell carcinoma, and other less frequent subtypes. Both subtypes and other solid tumors are increasingly regarded as abnormal organs, highlighting the critical role of the desmoplastic tumor stroma rich in cancer‐associated fibroblasts (CAFs) in driving tumor progression and therapeutic resistance. This tumor stroma resembles a chronic fibrotic wound and is largely formed by activated/myofibroblast‐like α‐SMA+ CAFs (myCAFs), which are strongly associated with immunosuppression and poor prognosis. Despite the dominance of the myCAF phenotype, we reported a decade ago phenotypic alterations in NSCLC with a strong dependence on the histologic subtype. Subsequent studies using functional assays, single‐cell techniques, and in vivo models have refined these initial observations, enhancing our understanding of the biology of both normal fibroblasts/myofibroblasts and CAFs in NSCLC and other cancer types, including their origins, subclassification, and physiopathologic functions. Notably, increasing evidence supports that CAFs can exhibit tumor‐restraining or tumor‐promoting effects, and current therapeutic efforts aim to shift the balance towards tumor‐restraining phenotypes. Here, we review major advances in our understanding of tumor stromagenesis and CAF heterogeneity in both primary tumors and metastasis, including emerging consensus, with a special focus on NSCLC and its frequent dissemination to the brain. We also highlight the critical role of smoking through epigenetic reprogramming of the TGF‐β/SMAD3 pathway. These advances are beginning to delineate how CAF heterogeneity depends on the stage and histologic subtype in NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsCancer-Associated FibroblastsTumor MicroenvironmentNeoplasm MetastasisHumansAnimalsEpigenesis, Genetic

Stichwörter der Autor:innen

cancer‐associated fibroblastsdesmoplasiametastasismyofibroblastsnon‐small cell lung cancerstromagenesis

Autor:innen und Institutionen

  • Unit of Biophysics and Bioengineering, Department of Biomedicine, University of Barcelona, Spain.
  • Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology (BIST), Spain.
  • Thoracic Oncology Unit, Hospital Clinic Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.

ORCID-Profile: Alejandro Bernardo, Natalia Díaz-Valdivia, Patricia Fernández-Nogueira, Jordi Alcaraz

Förderung

  • Ministerio de Ciencia, Innovación y Universidades (Agencia Estatal de Investigación AEI/FEDER, UE)
  • Instituto de Salud Carlos III
  • Fondo Nacional de Desarrollo Científico y Tecnológico
  • Fundación Científica Asociación Española Contra el Cáncer
  • Agència de Gestió d'Ajuts Universitaris i de Recerca
  • ERA-NET TRANSCAN-3
  • HORIZON EUROPE European Innovation Council

Zitieren

APA

Bernardo, A., Díaz-Valdivia, N., Fernández-Nogueira, P., & Alcaraz, J. (2025). Stromagenesis and cancer‐associated fibroblast heterogeneity in primary tumors and metastasis: focus in non‐small cell lung cancer. FEBS Open Bio, 15(10), 1599-1617. https://doi.org/10.1002/2211-5463.70102

Vancouver

Bernardo A, Díaz-Valdivia N, Fernández-Nogueira P, Alcaraz J. Stromagenesis and cancer‐associated fibroblast heterogeneity in primary tumors and metastasis: focus in non‐small cell lung cancer. FEBS Open Bio. 2025;15(10):1599-1617. doi:10.1002/2211-5463.70102

BibTeX
@article{Bernardo2025,
  author = {Bernardo, Alejandro and Díaz-Valdivia, Natalia and Fernández-Nogueira, Patricia and Alcaraz, Jordi},
  title = {Stromagenesis and cancer‐associated fibroblast heterogeneity in primary tumors and metastasis: focus in non‐small cell lung cancer},
  journal = {FEBS Open Bio},
  year = {2025},
  volume = {15},
  number = {10},
  pages = {1599--1617},
  doi = {10.1002/2211-5463.70102}
}
Kostenlos starten →